Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

IntroductionDiffuse Low-grade gliomas (DLGG, WHO Grade II) are a heterogenous group of tumors comprising 13–16% of glial tumors. While maximal safe resection is endorsed as the best approach to DLGG, compared to more conservative interventions like stereotactic biopsy, the added costs and risks have...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Kyle Tuohy, Djibril M. Ba, Debarati Bhanja, Douglas Leslie, Guodong Liu, Alireza Mansouri
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2023-02-01
Seri Bilgileri:	Frontiers in Surgery
Konular:	low-grade glioma (WHO grade II) cost resection stereotactic biopsy adverse events—complications MarketScan database
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fsurg.2023.1001741/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Early costs and complications of first-line low-grade glioma treatment using a large national database: Limitations and future perspectives

Benzer Materyaller